"An Extra Variable to Consider"-Vaccine-Induced Seropositivity and Adolescent HIV Vaccine Clinical Trials

被引：0
|
作者：
Fatola, Omolayo [1 ]
Corneli, Amy [2 ,3 ]
Perry, Brian [2 ]
Hanlen-Rosado, Emily [2 ]
Nsonwu, Adora [2 ]
Constantine, Evangelia P. [4 ]
Thompson, Amelia B. [5 ,6 ,7 ]
机构：
[1] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
[2] Duke Univ, Dept Populat Hlth Sci, Sch Med, Durham, NC USA
[3] Duke Univ, Duke Clin Res Inst, Sch Med, Durham, NC USA
[4] Dartmouth Coll, Hanover, NH 03755 USA
[5] Duke Univ, Duke Human Vaccine Inst, Sch Med, Durham, NC USA
[6] Duke Univ, Dept Pediat, Div Infect Dis, Sch Med, Durham, NC USA
[7] AdventHlth Children, Div Infect Dis, Dept Pediat, Orlando, FL 32803 USA
来源：
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY | 2022年 / 11卷 / 05期
关键词：
adolescent; HIV; prevention; vaccine; VISP;
D O I：
10.1093/jpids/piac001
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Our study explores the understanding of vaccine-induced seropositivity (VISP) and its potential impact on US adolescents' and caregivers' willingness to participate in adolescent HIV vaccine clinical trials. Findings from in-depth interviews suggest that addressing concerns about VISP will be essential for future pediatric HIV vaccine trials in the United States. Addressing adolescents' and their caregivers' concerns about vaccine-induced seropositivity will likely be essential to the success of future pediatric HIV vaccine trials in the United States.
引用
收藏
页码：221 / 224
页数：4
相关论文
共 50 条
  • [31] An HIV vaccine candidate enters clinical trials
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (12) : 2748 - 2748
  • [32] HIV VACCINE DEVELOPMENT AND CLINICAL-TRIALS
    HOFF, R
    MCNAMARA, J
    FOWLER, MG
    MCCAULEY, M
    ACTA PAEDIATRICA, 1994, 83 : 73 - 77
  • [33] Clinical features of vaccine-induced immune thrombocytopenia and therombosis
    Israeli, Eitan
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2021, 23 (11): : 734 - 734
  • [34] HIV type 1 vaccine-induced cytotoxic T cell responses in phase I clinical trials: Detection, characterization, and quantitation
    McElrath, MJ
    Siliciano, RF
    Weinhold, KJ
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (03) : 211 - 216
  • [35] Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis
    Pavord, Sue
    Scully, Marie
    Hunt, Beverley J.
    Lester, William
    Bagot, Catherine
    Craven, Brian
    Rampotas, Alex
    Ambler, Gareth
    Makris, Mike
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (18): : 1680 - 1689
  • [36] Simulating the effect of vaccine-induced immune responses on HIV infection
    Guardiola, J
    Izzo, G
    Vecchio, A
    HUMAN IMMUNOLOGY, 2003, 64 (09) : 840 - 851
  • [37] Impact of Vaccine Regimen on Vaccine-induced Antibody Durability
    Seaton, Kelly
    Palli, Rohith
    Key, Michelle
    Heptinstall, Jack
    Brackett, Caroline
    Fuchs, Jonathan
    Buchbinder, Susan
    Goepfert, Paul
    Robinson, Harriet
    Graham, Barney
    Maenza, Janine
    Hural, John
    Janes, Holly
    Huang, Yunda
    McElrath, Julie
    Keefer, Michael
    Kobie, James
    Tomaras, Georgia
    Thakar, Juilee
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 : 88 - 88
  • [38] HIV vaccine trials
    Des Jarlais, DC
    Vanichseni, S
    Marmor, M
    Kitayaporn, D
    SCIENCE, 1998, 279 (5356) : 1433 - 1434
  • [39] Educating community medical providers about HIV vaccine induced seropositivity
    Mark, K. E.
    Maenza, J.
    Garcia, D.
    Louis, K.
    Alexander, S. B.
    Moore, E.
    Broder, G. B.
    Wakefield, S.
    McElrath, M.
    RETROVIROLOGY, 2009, 6
  • [40] Adolescent participation in HIV vaccine trials: Cognitive developmental considerations
    Kafaar, Zuhayr
    Swartz, Leslie
    Kagee, Ashraf
    Lesch, Anthea
    Jaspan, Heather
    SOUTH AFRICAN JOURNAL OF PSYCHOLOGY, 2007, 37 (03) : 576 - 594
12345